COPENHAGEN — Novo Nordisk, the Danish pharmaceutical giant renowned for its diabetes and weight‑loss drugs including Ozempic, faced a major…
Read More
Novo Nordisk Slashes Obesity Drug Prices, Shaking Up the Weight-Loss Market
Copenhagen / New York — Novo Nordisk, the Danish pharmaceutical giant, has announced a substantial reduction in the cash price…
Read More
Novo Nordisk to Cut 9,000 Jobs as Competition Intensifies
Copenhagen, September 10, 2025 — Novo Nordisk, the pharmaceutical giant behind the blockbuster drugs Ozempic and Wegovy, announced a sweeping…
Read More
